Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2000
11/02/2000WO2000064891A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof
11/02/2000WO2000064888A1 Di-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064887A1 Renin inhibitors
11/02/2000WO2000064880A1 Selective npy (y5) antagonists
11/02/2000WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
11/02/2000WO2000064876A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064874A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000WO2000064873A1 Renin inhibitors
11/02/2000WO2000064486A2 Enzymatically activated polymeric drug conjugates
11/02/2000WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof
11/02/2000WO2000064474A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
11/02/2000WO2000064470A1 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/02/2000WO2000064468A2 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000WO2000064449A1 Thrombin inhibitors
11/02/2000WO2000064445A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
11/02/2000WO2000064443A1 Synergistic effects of amlodipine and atorvastatin
11/02/2000WO2000064438A1 Cardiovascular and bone treatment using isoflavones
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000064430A1 Apoptosis inhibitors
11/02/2000WO2000064426A2 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
11/02/2000WO2000064422A2 Novel treatment of neurotraumatic conditions with raf inhibitor
11/02/2000WO2000064420A2 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/02/2000WO2000064400A2 Methods for treating congestive heart failure
11/02/2000WO2000042216A3 Genetic predisposition to abnormal calcification conditions
11/02/2000WO2000042042A3 High affinity inhibitors for target validation and uses thereof
11/02/2000WO2000041726A3 Noninvasive vascular therapy
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040699A3 Astrocytes, their preparation and uses thereof
11/02/2000WO2000040584A3 Process for preparing n6-substituted deaza-adenosine derivatives
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000039083A3 Pyrazole compounds and uses thereof
11/02/2000WO2000037469B1 Process for preparing n6-substituted deaza-adenosine derivatives
11/02/2000WO1999063973A3 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1048657A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
11/02/2000EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047699A1 Platelet adp receptor inhibitors
11/02/2000EP1047695A1 Novel bispidine antiarrhythmic compounds
11/02/2000EP1047694A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
11/02/2000EP1047686A1 Substituted bicyclic lactones
11/02/2000EP1047685A1 Substituted beta,gamma-anellated lactones
11/02/2000EP1047684A1 Substituted alpha,beta-anellated butyrolactones
11/02/2000EP1047676A1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047664A1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
11/02/2000EP1047471A1 Systems and methods for local delivery of an agent
11/02/2000EP1047450A1 Ace inhibitor-mmp inhibitor combinations
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000EP1047421A2 Inhibition of lipoprotein oxidation
11/02/2000EP1047416A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis
11/02/2000EP1047411A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000EP1047299A1 Perfusion and/or preservation and/or re-perfusion solution during organ transplant
11/02/2000EP0853485A4 Therapeutic administration of hemoglobin in cardiac arrest
11/02/2000DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk
11/02/2000CA2372154A1 Process of purifying phytosterols from wood or plant-derived sources and compositions resulting therefrom
11/02/2000CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000CA2371274A1 Selective npy (y5) antagonists
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371217A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/02/2000CA2371064A1 Methods of delivery of cetyl myristoleate
11/02/2000CA2371046A1 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000CA2371008A1 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/02/2000CA2370639A1 Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
11/02/2000CA2370607A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
11/02/2000CA2370553A1 Cardiovascular and bone treatment using isoflavones
11/02/2000CA2370404A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
11/02/2000CA2370306A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000CA2370264A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000CA2370258A1 Thiazolidinedione derivative and its use as antidiabetic
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369999A1 Enzymatically activated polymeric drug conjugates
11/02/2000CA2369109A1 Thrombin inhibitors
11/02/2000CA2369092A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000CA2368213A1 Specifically targeted catalytic antagonists and uses thereof
11/02/2000CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/01/2000CN1272108A Indole derivatives as 5-HT1B and 5-HT1D agonists
11/01/2000CN1272107A Benzamidine derivatives as factor Xa inhibitors
11/01/2000CN1272060A Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition
11/01/2000CN1271731A New thiazole benzimidazole derivative
11/01/2000CN1271579A Compound vitamin for health of cardiovascular
11/01/2000CN1271577A Medicine preparation and its use and the use of high grade primary alcohol mixture
11/01/2000CN1058020C Angiotensin converting enzyme inhibitor and method for preparing same
11/01/2000CN1058019C 环状氨基酸衍生物 Cyclic amino acid derivatives
11/01/2000CN1058016C Sulphuric acid esters of amino-sugars, its salt for medicine, preparing process and use
11/01/2000CN1058013C Process for preparation of novel mercaptoacetylamide derivatives
11/01/2000CN1058004C Heterocyclo-benzoylguanidin
11/01/2000CN1058001C 4-Mercaptobenzoylguanidine derivatives
11/01/2000CN1057999C 4-Aminobenzoylguanidine derivatives
11/01/2000CN1057937C Use of lysozyme dimer and preparations containing same
11/01/2000CN1057930C Chinese medicine for treating deep phlebothrombosis
11/01/2000CN1057924C Drug preparation for curing viral and many kinds of myocarditis, low fever and hypokalemia
11/01/2000CN1057908C Use of hyaluronic acid and forms to prevent arterial restenosis
10/2000
10/31/2000US6141589 Switch control for external pacing system
10/31/2000US6140474 Monoclonal antibody reactive with human-origin CETP and method of quantifying human-origin CETP
10/31/2000US6140363 Administering rosmarinic acid, its derivative or prunella vulgaris extract for suppressing immune response for treatment, prevention, or diagnosis of rejection of transplanted organ or tissue, chronic rejection
1 ... 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 ... 1595